Hetero's Tocilizumab Gets DCGI Nod For COVID-19 Treatment of Hospitalised Adults
India.com News Desk | Sep 6, 2021, 2:30 PM IST
Hetero's Tocilizumab 400mg/20ml is the biosimilar version of Roche's Actemra/RoActemra and will be available from September end.




